High concentrations of POP combined with the downregulation of angiotensin-converting enzyme 2 (ACE2) have been observed in COVID-19; thus, a reduction in the enzyme’s activity could protect against lung injury [17,19]. The gene discussed is ACE2; the disease is COVID-19.